Explained herein are pharmaceutical packaging methods which avert oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate drugs, these units which includes a syringe by having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with really minimal permeability to oxygen and com